AROW: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	29,940	17,115
Provision for credit losses	6,428	5,613
Depreciation and amortization	4,130	2,619
Net gain on equity securities	669	277
Loans originated and held-for-sale	21,510	14,514
Proceeds from the sale of loans held-for-sale	19,875	11,013
Net gain on the sale of loans	573	314
Net loss (gain) on the sale of premises and equipment, other real estate owned and repossessed assets	-5	59
Contributions to retirement benefit plans	471	339
Deferred income tax expense (benefit)	179	-123
Shares issued under the directors stock plan	354	251
Stock-based compensation expense	547	422
Tax benefit from exercise of stock options	-111	-111
Net increase in other assets	1,285	-1,027
Net (decrease) increase in other liabilities	-1,690	-2,197
Net cash provided by operating activities	35,371	20,348
Proceeds from maturities, calls, and principal repayments of securities afs	82,191	68,437
Purchases of securities afs	87,781	39,623
Proceeds from maturities, calls, and principal repayments of securities htm	45,556	33,932
Purchases of securities htm	10,130	6,570
Purchase of equity securities	0	-
Net increase in loans	63,107	42,488
Termination of fair value hedge	3,017	-
Proceeds from sales of premises and equipment, oreo and repos	2,285	1,439
Purchases of premises and equipment	4,015	3,276
(purchase) redemption of fhlb stock	16	204
Acquisition of whitehall branch (net cash received)	0	-
Net cash (used) provided by investing activities	-38,034	11,647
Net increase in deposits	272,121	101,400
Finance lease payments	77	36
Other borrowings - advances	0	0
Other borrowings - paydowns	4,335	0
Net cash collateral received from (paid to) derivative counterparties	2,560	-
Termination of cash flow hedge	847	-
Purchase of treasury stock	10,086	8,654
Stock options exercised, net	102	102
Shares issued under espp	244	165
Net cash collateral (paid to) received from derivative counterparties	-	-1,710
Cash dividends paid	14,128	9,360
Net cash provided by financing activities	245,554	81,907
Net increase in cash and cash equivalents	242,891	113,902
Cash and cash equivalents at beginning of period	154,546	-
Cash and cash equivalents at end of period	397,437	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

AROW: the cashflow